目的:探究血清Kruppel样因子5(recombinant Kruppel factor 5,KLF5)含量与阳性淋巴结比例的相关性及其对膀胱癌患者根治术后预后的预测价值。方法:选取新乡市中心医院和郑州大学第一附属医院泌尿外科2019年6月至2022年9月进行根治性膀...目的:探究血清Kruppel样因子5(recombinant Kruppel factor 5,KLF5)含量与阳性淋巴结比例的相关性及其对膀胱癌患者根治术后预后的预测价值。方法:选取新乡市中心医院和郑州大学第一附属医院泌尿外科2019年6月至2022年9月进行根治性膀胱切除术治疗的92例膀胱癌患者作为研究对象,根据疗效分为有效组和无效组。酶联免疫吸附法检测血清KLF5的表达水平、分析血清KLF5含量与阳性淋巴结比例的相关性和预后的预测价值分析。结果:治疗有效组患者血清KLF5的表达水平显著低于无效组(P<0.05);有效组患者阳性淋巴结比例与无效组相比,具有显著差异(P<0.05);采用Pearson分析血清KLF5与阳性淋巴结比例间关系,发现血清KLF5与阳性淋巴结比例呈正相关(r=0.607);logistic多因素回归分析显示,血清KLF5(OR=2.751,95%CI=1.777~4.260,P=0.000)与阳性淋巴结比例(OR=2.751,95%CI=1.389~7.342,P=0.006)是影响膀胱癌根治术患者病情预后的独立危险因素;ROC结果显示,血清KLF5与阳性淋巴结比例对预测膀胱癌根治术患者预后的曲线下面积(area under the curve,AUC)分别为0.909、0.748,对应灵敏度分别为80.71%、93.26%,特异度分别为91.24%、92.50%。二者联合诊断的AUC为0.929,灵敏度和特异度分别为92.30%和92.50%。结论:血清KLF5和阳性淋巴结比例是膀胱根治术患者预后的独立危险因素,并且KLF5与患者的阳性淋巴结比例呈正相关,因此在预测膀胱根治术患者预后的过程中,动态检测相关影响因素的变化可以为临床医生诊断病情提供依据。展开更多
Objective:To explore the role of circROBO1 in promoting the invasion of retinal Y79 cells by targeting KLF5 and its possible regulatory mechanism.Methods:RNase R enzyme digestion and qRT-PCR experiments were used to d...Objective:To explore the role of circROBO1 in promoting the invasion of retinal Y79 cells by targeting KLF5 and its possible regulatory mechanism.Methods:RNase R enzyme digestion and qRT-PCR experiments were used to detect the structural stability of circular circROBO1 in retinal Y79 cells;cytoplasmic and nuclear RNAs of retinal Y79 cells were extracted for localization analysis of circROBO1;The expression of circROBO1 in retinal Y79 cells were silenced by siRNA.The effect of circROBO1 on the migration and invasion ability of HT-29 cells was detected by scratch assay,Transwell cell invasion and migration assay.The target binding sites of circROBO1 and its downstream miRNA and that of miRNA and its downstream target gene KLF5 were predicted by CircInteractome and TargetScan online software respectively,and the target regulation relationship between them was verified by double luciferase reporter gene experiment.Western blot was used to detect the effect of siRNA silencing the expression of circROBO1 in Y79 cells on the expression of KLF5.Results:Compared with the control group without RNase R enzyme treatment,relative circROBO1 levels did not change significantly after treatment,while relative linear ROBO1 levels decreased significantly after treatment(t=16.18,P<0.05);the content of circROBO1 in the cytoplasm was significantly higher than that in the nucleus(P<0.05);compared with si-control group,the migration rate and the invasion and migration abilities of Transwell cells were all lower in the si-circROBO1 group(t=22.54,P<0.05);circROBO1 can adsorb miR-885-5p,and there is a target binding site between miR-885-5p and KLF5(t=11.39,P<0.05);compared with the si-control group,the KLF5 protein expression in the si-circROBO1 group was significantly decreased(t=17.26,P<0.05).Conclusions:circROBO1 promotes retinalY79 cell tumor invasion by targeting KLF5.展开更多
文摘目的:探究血清Kruppel样因子5(recombinant Kruppel factor 5,KLF5)含量与阳性淋巴结比例的相关性及其对膀胱癌患者根治术后预后的预测价值。方法:选取新乡市中心医院和郑州大学第一附属医院泌尿外科2019年6月至2022年9月进行根治性膀胱切除术治疗的92例膀胱癌患者作为研究对象,根据疗效分为有效组和无效组。酶联免疫吸附法检测血清KLF5的表达水平、分析血清KLF5含量与阳性淋巴结比例的相关性和预后的预测价值分析。结果:治疗有效组患者血清KLF5的表达水平显著低于无效组(P<0.05);有效组患者阳性淋巴结比例与无效组相比,具有显著差异(P<0.05);采用Pearson分析血清KLF5与阳性淋巴结比例间关系,发现血清KLF5与阳性淋巴结比例呈正相关(r=0.607);logistic多因素回归分析显示,血清KLF5(OR=2.751,95%CI=1.777~4.260,P=0.000)与阳性淋巴结比例(OR=2.751,95%CI=1.389~7.342,P=0.006)是影响膀胱癌根治术患者病情预后的独立危险因素;ROC结果显示,血清KLF5与阳性淋巴结比例对预测膀胱癌根治术患者预后的曲线下面积(area under the curve,AUC)分别为0.909、0.748,对应灵敏度分别为80.71%、93.26%,特异度分别为91.24%、92.50%。二者联合诊断的AUC为0.929,灵敏度和特异度分别为92.30%和92.50%。结论:血清KLF5和阳性淋巴结比例是膀胱根治术患者预后的独立危险因素,并且KLF5与患者的阳性淋巴结比例呈正相关,因此在预测膀胱根治术患者预后的过程中,动态检测相关影响因素的变化可以为临床医生诊断病情提供依据。
基金Key Project of Hunan Provincial Department of Education(No.21A0285)。
文摘Objective:To explore the role of circROBO1 in promoting the invasion of retinal Y79 cells by targeting KLF5 and its possible regulatory mechanism.Methods:RNase R enzyme digestion and qRT-PCR experiments were used to detect the structural stability of circular circROBO1 in retinal Y79 cells;cytoplasmic and nuclear RNAs of retinal Y79 cells were extracted for localization analysis of circROBO1;The expression of circROBO1 in retinal Y79 cells were silenced by siRNA.The effect of circROBO1 on the migration and invasion ability of HT-29 cells was detected by scratch assay,Transwell cell invasion and migration assay.The target binding sites of circROBO1 and its downstream miRNA and that of miRNA and its downstream target gene KLF5 were predicted by CircInteractome and TargetScan online software respectively,and the target regulation relationship between them was verified by double luciferase reporter gene experiment.Western blot was used to detect the effect of siRNA silencing the expression of circROBO1 in Y79 cells on the expression of KLF5.Results:Compared with the control group without RNase R enzyme treatment,relative circROBO1 levels did not change significantly after treatment,while relative linear ROBO1 levels decreased significantly after treatment(t=16.18,P<0.05);the content of circROBO1 in the cytoplasm was significantly higher than that in the nucleus(P<0.05);compared with si-control group,the migration rate and the invasion and migration abilities of Transwell cells were all lower in the si-circROBO1 group(t=22.54,P<0.05);circROBO1 can adsorb miR-885-5p,and there is a target binding site between miR-885-5p and KLF5(t=11.39,P<0.05);compared with the si-control group,the KLF5 protein expression in the si-circROBO1 group was significantly decreased(t=17.26,P<0.05).Conclusions:circROBO1 promotes retinalY79 cell tumor invasion by targeting KLF5.
